BRCA2 is a tumor suppressor best known for mutations associated with hereditary breast and ovarian cancer, but mutations are also associated with predisposition to other cancers including childhood leukemia and neuroblastoma [31,35]. This evidence concerns the gene BRCA2 and neoplasm.